Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Vibramycin 50 capsules
0501030I0BEAAAA
|
Vibramycin | Doxycycline hyclate | Infections | No data available |
|
Vibramycin Acne Pack 50mg capsules
0501030I0BEAEAA
|
Vibramycin | Doxycycline hyclate | Infections | No data available |
|
Vibrox 100mg capsules
0501030I0BLAAAB
|
Vibrox | Doxycycline hyclate | Infections | No data available |
|
Victrelis 200mg capsules
0503032A0BBAAAA
|
Victrelis | Boceprevir | Infections | No data available |
|
Videx 150mg chewable dispersible tablets
0503010N0BBADAD
|
Videx | Didanosine | Infections | No data available |
|
Videx 200mg chewable dispersible tablets
0503010N0BBAEAE
|
Videx | Didanosine | Infections | No data available |
|
Videx 25mg chewable dispersible tablets
0503010N0BBACAC
|
Videx | Didanosine | Infections | No data available |
|
Videx EC 125mg capsules
0503010N0BBAFAF
|
Videx | Didanosine | Infections | No data available |
|
Videx EC 200mg capsules
0503010N0BBAGAG
|
Videx | Didanosine | Infections | No data available |
|
Videx EC 250mg capsules
0503010N0BBAHAH
|
Videx | Didanosine | Infections | No data available |
|
Videx EC 400mg capsules
0503010N0BBAIAI
|
Videx | Didanosine | Infections | No data available |
|
Viekirax 12.5mg/75mg/50mg tablets
0503032G0BBAAAA
|
Viekirax | Paritaprevir/ritonavir/ombitasvir | Infections | No data available |
|
Viracept 250mg tablets
0503010C0BBAAAA
|
Viracept | Nelfinavir mesilate | Infections | No data available |
|
Viracept 50mg/g oral powder
0503010C0BBABAB
|
Viracept | Nelfinavir mesilate | Infections | No data available |
|
Viramune 100mg modified-release tablets
0503010B0BBADAD
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 200mg tablets
0503010B0BBAAAA
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 400mg modified-release tablets
0503010B0BBAEAE
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 50mg modified-release tablets
0503010B0BBACAC
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 50mg/5ml oral suspension
0503010B0BBABAB
|
Viramune | Nevirapine | Infections | No data available |
|
Virazole 1.2g/12ml solution for injection vials
0503050B0BCACAI
|
Virazole | Ribavirin | Infections | No data available |
|
Virazole 6g powder for nebuliser solution vials
0503050B0BCABAA
|
Virazole | Ribavirin | Infections | No data available |
|
Viread 123mg tablets
0503010H0BBACAC
|
Viread | Tenofovir disoproxil | Infections | No data available |
|
Viread 163mg tablets
0503010H0BBADAD
|
Viread | Tenofovir disoproxil | Infections | No data available |
|
Viread 204mg tablets
0503010H0BBAEAE
|
Viread | Tenofovir disoproxil | Infections | No data available |
|
Viread 33mg/g granules
0503010H0BBABAB
|
Viread | Tenofovir disoproxil | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.